These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8287504)

  • 1. Breaking the thrombolytic gridlock: insights from the GUSTO trial.
    Topol EJ
    Cleve Clin J Med; 1993; 60(6):445-7. PubMed ID: 8287504
    [No Abstract]   [Full Text] [Related]  

  • 2. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GUSTO trial: is the open-artery hypothesis proven?
    Stringer KA; Lindenfeld J
    Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
    [No Abstract]   [Full Text] [Related]  

  • 5. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic agents in critical care.
    Weiner B
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):355-66. PubMed ID: 8398041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
    Califf RM; Topol EJ
    Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Friedman HS
    N Engl J Med; 1994 Feb; 330(7):504; author reply 505-6. PubMed ID: 8289861
    [No Abstract]   [Full Text] [Related]  

  • 10. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
    Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
    J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy for acute myocardial infarction in the elderly.
    Straznicky IT; White HD
    Coron Artery Dis; 2000 Jun; 11(4):299-304. PubMed ID: 10860172
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy.
    Goldhaber SZ
    Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on the GUSTO Trial.
    Lomaestro BM
    Ann Intern Med; 1994 Nov; 121(10):818-9. PubMed ID: 7944069
    [No Abstract]   [Full Text] [Related]  

  • 16. Issues raised by GUSTO.
    White H
    Aust N Z J Med; 1993 Dec; 23(6):739-41. PubMed ID: 8141715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the use of t-PA as compared with streptokinase cost effective?
    Rose EA
    N Engl J Med; 1995 Oct; 333(15):1009; author reply 1010. PubMed ID: 7666904
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
    Zahn R; Rustige J; Koch A; Schiele R; Burczyk U; Schuster S; Harmjanz D; Boppert D; Gottwik M; Neuhaus KL; Senges J
    Am J Cardiol; 1997 Nov; 80(10):1339-43. PubMed ID: 9388110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.